<code id='84C1A09A47'></code><style id='84C1A09A47'></style>
    • <acronym id='84C1A09A47'></acronym>
      <center id='84C1A09A47'><center id='84C1A09A47'><tfoot id='84C1A09A47'></tfoot></center><abbr id='84C1A09A47'><dir id='84C1A09A47'><tfoot id='84C1A09A47'></tfoot><noframes id='84C1A09A47'>

    • <optgroup id='84C1A09A47'><strike id='84C1A09A47'><sup id='84C1A09A47'></sup></strike><code id='84C1A09A47'></code></optgroup>
        1. <b id='84C1A09A47'><label id='84C1A09A47'><select id='84C1A09A47'><dt id='84C1A09A47'><span id='84C1A09A47'></span></dt></select></label></b><u id='84C1A09A47'></u>
          <i id='84C1A09A47'><strike id='84C1A09A47'><tt id='84C1A09A47'><pre id='84C1A09A47'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:focus    Page View:72
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In